PRONELFENE

PHARMACEUTICALS, NAMELY, IMPLANTABLE DRUG DELIVERY SYSTEM COMPRISED PRIMARILY OF SUSTAINED RELEASE DRUGS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, CANCER AND OTHER SERIOUS AND LIFE-THREATENING DISEASES